Sarah M Bair, MD | |
776 W Eisenhower Blvd, Loveland, CO 80537-3157 | |
(970) 667-3116 | |
(970) 278-0434 |
Full Name | Sarah M Bair |
---|---|
Gender | Female |
Speciality | Dermatology |
Experience | 18 Years |
Location | 776 W Eisenhower Blvd, Loveland, Colorado |
Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1760670863 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ND0900X | Dermatology - Dermatopathology | DR-48408 (Colorado) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Boulder Community Health | Boulder, CO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Crossroads Dermatology Llc | 9537419601 | 2 |
News Archive
Toys, appliances, and even a sofa and coffee table can impact the way or when a baby first crawls, walks or achieves other growth milestones, but a new UT Arlington study finds that many parents are unaware of the significant role household items play in their infant's motor skill development.
Xiaoquan Zhao, Ph.D. Director/Faculty, Communication, received $28,707 from the Food and Drug Administration for research support for the FDA's Youth Tobacco Education Campaigns.
Systematic, progressive resistance training - also called strength training - is a safe and efficient way for middle-aged and older adults to improve their health. A Virginia Tech led research team that includes experts in behavior, exercise, physiology, and medicine is designing a program to help pre-diabetic adults begin and, most important, maintain resistance training in order to prevent diabetes.
Spectrum Pharmaceuticals today announced that it has submitted an investigational new drug (IND) application to the U.S. Food & Drug Administration for SPI-014 (previously referred to as RENAZORB), a second-generation lanthanum-based nanoparticle phosphate binding agent, that has the potential to treat hyperphosphatemia in patients with Stage 5 chronic kidney disease, or end-stage renal disease (ESRD).
Although patients with chronic conditions who do not take medications as prescribed tend to have poorer health outcomes and higher health care costs than those who adhere to medication regimens, a new report sheds light on the potential for multiple interventions to improve medication adherence.
› Verified 4 days ago
Entity Name | Crossroads Dermatology Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1558853846 PECOS PAC ID: 9537419601 Enrollment ID: O20180911002448 |
News Archive
Toys, appliances, and even a sofa and coffee table can impact the way or when a baby first crawls, walks or achieves other growth milestones, but a new UT Arlington study finds that many parents are unaware of the significant role household items play in their infant's motor skill development.
Xiaoquan Zhao, Ph.D. Director/Faculty, Communication, received $28,707 from the Food and Drug Administration for research support for the FDA's Youth Tobacco Education Campaigns.
Systematic, progressive resistance training - also called strength training - is a safe and efficient way for middle-aged and older adults to improve their health. A Virginia Tech led research team that includes experts in behavior, exercise, physiology, and medicine is designing a program to help pre-diabetic adults begin and, most important, maintain resistance training in order to prevent diabetes.
Spectrum Pharmaceuticals today announced that it has submitted an investigational new drug (IND) application to the U.S. Food & Drug Administration for SPI-014 (previously referred to as RENAZORB), a second-generation lanthanum-based nanoparticle phosphate binding agent, that has the potential to treat hyperphosphatemia in patients with Stage 5 chronic kidney disease, or end-stage renal disease (ESRD).
Although patients with chronic conditions who do not take medications as prescribed tend to have poorer health outcomes and higher health care costs than those who adhere to medication regimens, a new report sheds light on the potential for multiple interventions to improve medication adherence.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Sarah M Bair, MD 776 W Eisenhower Blvd, Loveland, CO 80537-3157 Ph: (970) 667-3116 | Sarah M Bair, MD 776 W Eisenhower Blvd, Loveland, CO 80537-3157 Ph: (970) 667-3116 |
News Archive
Toys, appliances, and even a sofa and coffee table can impact the way or when a baby first crawls, walks or achieves other growth milestones, but a new UT Arlington study finds that many parents are unaware of the significant role household items play in their infant's motor skill development.
Xiaoquan Zhao, Ph.D. Director/Faculty, Communication, received $28,707 from the Food and Drug Administration for research support for the FDA's Youth Tobacco Education Campaigns.
Systematic, progressive resistance training - also called strength training - is a safe and efficient way for middle-aged and older adults to improve their health. A Virginia Tech led research team that includes experts in behavior, exercise, physiology, and medicine is designing a program to help pre-diabetic adults begin and, most important, maintain resistance training in order to prevent diabetes.
Spectrum Pharmaceuticals today announced that it has submitted an investigational new drug (IND) application to the U.S. Food & Drug Administration for SPI-014 (previously referred to as RENAZORB), a second-generation lanthanum-based nanoparticle phosphate binding agent, that has the potential to treat hyperphosphatemia in patients with Stage 5 chronic kidney disease, or end-stage renal disease (ESRD).
Although patients with chronic conditions who do not take medications as prescribed tend to have poorer health outcomes and higher health care costs than those who adhere to medication regimens, a new report sheds light on the potential for multiple interventions to improve medication adherence.
› Verified 4 days ago
Holly Hare Mccoppin, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3451 Mountain Lion Dr, Loveland, CO 80537 Phone: 970-800-9330 Fax: 720-927-4301 | |
Dr. David P Clark, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 776 W Eisenhower Blvd, Loveland, CO 80537 Phone: 970-667-3116 Fax: 970-669-0159 | |
Kevin John Mott, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1708 Boise Ave, Loveland, CO 80538 Phone: 970-667-3116 Fax: 970-669-0159 | |
Dr. Ingerlisa Wenche Mattoch, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1708 N. Boise, Loveland, CO 80538 Phone: 970-818-6788 Fax: 970-669-0159 | |
Bruce W Kornfeld, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 1907 Boise Ave, Loveland, CO 80538 Phone: 970-682-3377 Fax: 970-682-3340 | |
Dr. Jordan Fabrikant, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1907 Boise Ave Ste 3, Loveland, CO 80538 Phone: 970-682-3377 Fax: 970-683-3340 |